Cargando…
FRI123 Development And Impact Of A Best Practice Alert For Primary Aldosteronism Screening
Disclosure: S. Charoensri: None. L. Bashaw: None. C. Dehmlow: None. T. Ellies: None. A.F. Turcu: None. Background: Primary aldosteronism (PA) is a common cause of secondary hypertension, affecting up to 25% of patients with treatment-resistant hypertension. PA amplifies the risk of cardiovascular mo...
Autores principales: | Charoensri, Suranut, Bashaw, Linda, Dehmlow, Cheryl, Ellies, Tammy, Turcu, Adina F |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10553576/ http://dx.doi.org/10.1210/jendso/bvad114.636 |
Ejemplares similares
-
FRI122 Determinants Of Primary Aldosteronism Screening In The US: A Nationwide Physician Survey Study
por: Turcu, Adina F, et al.
Publicado: (2023) -
SAT-561 Effects of Mineralocorticoid Receptor Antagonists on Primary Aldosteronism Screening
por: Tezuka, Yuta, et al.
Publicado: (2020) -
Rates of Primary Aldosteronism Screening Among High-Risk Populations
por: Grigoryan, Seda, et al.
Publicado: (2021) -
SAT-564 Effectiveness of Treatment with Mineralocorticoid Receptor Antagonistsin Primary Aldosteronism
por: Tezuka, Yuta, et al.
Publicado: (2020) -
SAT-067 Insights into Paradoxical Bilateral Aldosterone Suppression in the Adrenal Veins of Patients with Primary Aldosteronism
por: Wannachalee, Taweesak, et al.
Publicado: (2019)